RBC Capital analyst Michael Carroll raised his price target on Welltower to $76 after its Q4 results and affirmed FY19 guidance, saying the company should see earnings growth trending modestly higher given its aggressive capital deployment over the past several quarters. The analyst also keeps his Sector Perform rating on the shares, stating that while Welltower's in-place portfolio should generate healthy growth, the "increase in senior housing supply and the uncertain skilled nursing facilities reimbursement environment will add incremental pressure ".